Turtle Creek Wealth Advisors LLC raised its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 5.5% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 63,940 shares of the financial services provider’s stock after purchasing an additional 3,345 shares during the period. Turtle Creek Wealth Advisors LLC’s holdings in Aflac were worth $6,743,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. NorthRock Partners LLC increased its holdings in shares of Aflac by 1.5% in the first quarter. NorthRock Partners LLC now owns 6,519 shares of the financial services provider’s stock worth $725,000 after purchasing an additional 95 shares during the period. Valued Wealth Advisors LLC increased its holdings in shares of Aflac by 24.4% in the first quarter. Valued Wealth Advisors LLC now owns 495 shares of the financial services provider’s stock worth $55,000 after purchasing an additional 97 shares during the period. Duncan Williams Asset Management LLC increased its holdings in shares of Aflac by 5.0% in the second quarter. Duncan Williams Asset Management LLC now owns 2,065 shares of the financial services provider’s stock worth $218,000 after purchasing an additional 98 shares during the period. Phillips Wealth Planners LLC increased its holdings in shares of Aflac by 1.5% in the first quarter. Phillips Wealth Planners LLC now owns 6,653 shares of the financial services provider’s stock worth $711,000 after purchasing an additional 100 shares during the period. Finally, Stiles Financial Services Inc increased its holdings in shares of Aflac by 3.4% in the second quarter. Stiles Financial Services Inc now owns 3,070 shares of the financial services provider’s stock worth $324,000 after purchasing an additional 100 shares during the period. 67.44% of the stock is owned by institutional investors.
Aflac Stock Performance
NYSE AFL opened at $109.80 on Thursday. The company has a 50-day simple moving average of $108.18 and a two-hundred day simple moving average of $105.52. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a 12-month low of $96.95 and a 12-month high of $115.44. The firm has a market cap of $58.73 billion, a price-to-earnings ratio of 24.90, a PEG ratio of 3.09 and a beta of 0.86.
Aflac announced that its board has initiated a stock repurchase plan on Tuesday, August 12th that allows the company to buyback 100,000,000 shares. This buyback authorization allows the financial services provider to repurchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.
Aflac Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 2nd. Shareholders of record on Wednesday, August 20th were given a dividend of $0.58 per share. This represents a $2.32 annualized dividend and a yield of 2.1%. The ex-dividend date was Wednesday, August 20th. Aflac’s dividend payout ratio is presently 52.61%.
Insider Transactions at Aflac
In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $102.57, for a total transaction of $102,570.00. Following the completion of the sale, the director directly owned 25,105 shares in the company, valued at $2,575,019.85. This represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 0.90% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several research analysts have recently weighed in on AFL shares. Morgan Stanley upped their price target on shares of Aflac from $108.00 to $113.00 and gave the stock an “equal weight” rating in a report on Monday, August 18th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Aflac in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Aflac from a “sell” rating to a “hold” rating in a research report on Saturday, August 9th. Barclays reiterated an “underweight” rating and issued a $102.00 target price (up from $100.00) on shares of Aflac in a research report on Wednesday, October 8th. Finally, Piper Sandler set a $125.00 target price on shares of Aflac and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Three analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $109.45.
Read Our Latest Stock Report on Aflac
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Recommended Stories
- Five stocks we like better than Aflac
- How to trade using analyst ratings
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Ride Out The Recession With These Dividend Kings
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Where Do I Find 52-Week Highs and Lows?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.